Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.58 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | APAF1 | O14727 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.48 |
| ▸ | MPI | P34949 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15886144 | 1.00 | CYP1B1 (0.58) | CYP1B1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL15383768 | 0.87 | MEN1 (0.57) | CYP1B1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL14329987 | 0.85 | KMT2A (0.55) | CYP1B1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL28566950 | 0.84 | HEXA (0.57) | CYP1B1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL16085321 | 0.83 | ALDH1A1 (0.61) | CYP1B1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL19465787 | 0.82 | KMT2A (0.39) | CYP1B1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL21670093 | 0.81 | KMT2A (0.37) | CYP1B1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL14463546 | 0.80 | SIRT1 (0.61) | MEN1KMT2AUSP2ATML3MBTL1 | |
| SCHEMBL27805161 | 0.79 | ALDH1A1 (0.44) | CYP1B1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL19465763 | 0.79 | MEN1 (0.46) | CYP1B1ALDH1A1KDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12545644-B2 | 6-azido-1.3 benzo[de]isoquinoline compounds photo-crosslinked by visible light and uses thereof | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2026-02-10 | — | — | US | disclosed |
| US-20240182425-A1 | NOVEL COMPOUNDS PHOTO-CROSSLINKED BY VISIBLE LIGHT AND USES THEREOF | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2024-06-06 | — | — | US | disclosed |
| EP-4102227-A1 | NOVEL COMPOUND TO BE PHOTO-CROSSLINKED BY VISIBLE LIGHT, AND USE THEREOF | Seoul National University R & DB Foundation (KR) | 2022-12-14 | — | — | EP | disclosed |
| WO-2022220581-A1 | NOVEL COMPOUND TO BE PHOTO-CROSSLINKED BY VISIBLE LIGHT, AND USE THEREOF | 서울대학교산학협력단 | 2022-10-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545644-B2 | 6-azido-1.3 benzo[de]isoquinoline compounds photo-crosslinked by visible light and uses thereof | CEP170, PCNA, PER2 | CYP1B1 3082/4885ALDH1A1 3031/4885KDM4E 1958/4885 |
| US-20240182425-A1 | NOVEL COMPOUNDS PHOTO-CROSSLINKED BY VISIBLE LIGHT AND USES THEREOF | DCLRE1A, DDB1, RAET1L | CYP1B1 4347/4885ALDH1A1 3190/4885KDM4E 2934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.